Screener
Mirum Pharmaceuticals, Inc. MIRM Enterprise value
Enterprise value at other companies
Other financials
Where this comes from
Calculated from Mirum Pharmaceuticals, Inc.’s reported figures.
The source filing: Mirum Pharmaceuticals, Inc.’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 4:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001759425-26-000045
FAQ
- What is Mirum Pharmaceuticals, Inc.'s enterprise value?
- Mirum Pharmaceuticals, Inc. (MIRM) reported enterprise value of $6.89B in Q2 2026.
- How has Mirum Pharmaceuticals, Inc.'s enterprise value changed year-over-year?
- Mirum Pharmaceuticals, Inc.'s enterprise value increased by 192.7% year-over-year, from $2.35B to $6.89B.
- What is the long-term trend for Mirum Pharmaceuticals, Inc.'s enterprise value?
- Over 5 years (2020 to 2025), Mirum Pharmaceuticals, Inc.'s enterprise value has grown at a 57.5% compound annual growth rate (CAGR), from $396.12M to $3.84B.
- What does enterprise value mean?
- Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.
Ask your AI about Mirum Pharmaceuticals, Inc.'s enterprise value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude